Review: doxorubicin delivery systems based on chitosan for cancer therapy. (Q37380142)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19178759%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

review article

1 reference

title

Review: doxorubicin delivery systems based on chitosan for cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19178759%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19178759%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Peter Choong

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19178759%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1

Mei Lin Tan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19178759%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

4

Crispin R Dass

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19178759%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

1 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19178759%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pharmacy and Pharmacology

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19178759%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19178759%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19178759%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

131-142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19178759%20AND%20SRC:MED&resulttype=core&format=json

The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines.

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Anthracycline cardiotoxicity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Liposomal encapsulated anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

21 January 2018

Liposomal nanomedicines

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Dextran-coated gold nanoparticles for the assessment of antimicrobial susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Downregulation of c-jun results in apoptosis-mediated anti-osteosarcoma activity in an orthotopic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

c-Jun Is critical for the progression of osteosarcoma: proof in an orthotopic spontaneously metastasizing model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

c-Jun knockdown sensitizes osteosarcoma to doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Chitosan--as a biomaterial

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Design of nanoparticles composed of graft copolymers for oral peptide delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

In vitro degradation of chitosan by a commercial enzyme preparation: effect of molecular weight and degree of deacetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Chitosan induces apoptosis via caspase-3 activation in bladder tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Dendrimeric poly(propylene-imines) as effective delivery agents for DNAzymes: toxicity, in vitro transfection and in vivo delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Targeting cancer cells with DNA-assembled dendrimers: a mix and match strategy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Dendrimer biocompatibility and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-alpha delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Gold nanoparticles as carriers for efficient transmucosal insulin delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Liposomes as carriers of antitumor agents: toward a clinical reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Drug delivery in cancer using liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

A microsphere-liposome (microplex) vector for targeted gene therapy of cancer. II. In vivo biodistribution study in a solid tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Particle-mediated intravascular delivery of oligonucleotides to tumors: associated biology and lessons from genotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Liposomes containing cationic dimethyl dioctadecyl ammonium bromide: formulation, quality control, and lipofection efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Involvement of c-jun in human liposarcoma growth: supporting data from clinical immunohistochemistry and DNAzyme efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Chitosan-based gastrointestinal delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Nanoparticles in cancer therapy and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Preparation of doxorubicin-containing chitosan microspheres for transcatheter arterial chemoembolization of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Hollow chitosan/poly(acrylic acid) nanospheres as drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Studies on alginate-chitosan microcapsules and renal arterial embolization in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Hollow chitosan-alginate multilayer microcapsules as drug delivery vehicle: doxorubicin loading and in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Fuzzy Nanoassemblies: Toward Layered Polymeric Multicomposites

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Tailor-made polyelectrolyte microcapsules: from multilayers to smart containers

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Formulation and cytotoxicity of doxorubicin loaded in self-assembled bio-polyelectrolyte microshells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Nanomedicine: current status and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Therapeutic effects of Holmium-166 chitosan complex in rat brain tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Polymeric micellar pH-sensitive drug delivery system for doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Thermosensitive Y-shaped micelles of poly(oleic acid-Y-N-isopropylacrylamide) for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Preparation and characterization of N-succinyl-N'-octyl chitosan micelles as doxorubicin carriers for effective anti-tumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

Doxorubicin in sterically stabilized liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.02.0001

21 January 2018

Identifiers

DOI

10.1211/JPP.61.02.0001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19178759%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference